DOCSLIB.ORG

New Chief Executive As MRC Gets Cash Boost

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New Chief Executive As MRC Gets Cash Boost AUTUMN 2007 News from the Medical Research Council New Chief Executive as MRC gets cash boost A new Chief Executive, Sir Leszek Borysiewicz, took the helm of the MRC at the beginning of October. Sir Leszek, who comes from Imperial College London where he was Deputy Rector, spoke of his excitement about leading the MRC at a time of change and opportunity for the organisation: “I’m thrilled by the chance to work across the whole spectrum of biomedical science and to help to make a difference in relation to healthcare for individuals in the UK and globally.” The chairman of the MRC, Sir John Chisholm, welcomed Sir Leszek: “He is the perfect person to lead the MRC in the new environment of coordinated health research in the UK. I am delighted he’ll join us – his stature as a scientist and clinician reflects the importance of the role the MRC will play in a coordinated strategy for turning research findings into healthcare.” Timely arrival Sir Leszek joined the MRC just days before the Chancellor announced a significant increase in the organisation’s budget, from £543 million to £682 million a year by 2010. In his pre-budget report to the House of Commons on 10 October, Alistair Darling explained that he was funding recognised across the world. And so more British medical discovery can in full the recommendations of Sir David Cooksey’s review of publicly be translated into new health drugs, treatments and preventions… We funded health research including a single strategy for health research in will expand the single fund for health research to £1.7 billion by 2010.” the UK overseen by an Office for the Strategic Coordination of Health Research (OSCHR). Commenting on behalf of the MRC, Sir Leszek described the settlement as a great opportunity: “This significant government boost for health Mr Darling said: “Britain has more Nobel prize winners than any country research in the UK will maintain and strengthen the foundations of basic outside the USA. Yesterday another prize was awarded for medical biomedical science in the UK. But it will also enable researchers to do research, which is testament to Britain’s continued scientific success, more to translate discoveries into benefits for patients and society.” ‘Father of stem cell research’ wins Nobel Prize MRC-funded scientist Sir Martin Evans, has been awarded the 2007 Nobel Prize in Physiology or Medicine alongside Italian and UK-born US citizens Mario Capecchi and Oliver Smithies for their discoveries of “principles for introducing specific gene modifications in mice by the use of embryonic stem cells”. Sir Martin, former Director of the School of Biosciences and Professor of Mammalian Genetics of Cardiff University, has been supported throughout his career by the MRC. He was a pioneer in UK stem cell research 20 years ago at Cambridge University when he developed ways to culture embryonic stem cells derived from the mouse blastocyst – the ball of cells formed after fertilisation. He wins the prize for his work in gene targeting, a technique used to inactivate single genes. With gene targeting it is now possible to produce almost any type of DNA modification in the mouse genome, allowing scientists to establish the roles of individual genes in health and disease. Read more abour Sir Martin’s work at www.mrc.ac.uk/NewsViewsAndEvents/News. NEW CHIEF EXECUTIVE AS MRC GETS CASH BOOST continued He went on: “The alignment of the MRC, the Department of The CSR also sees a budget increase for NIHR from £753 million in Health’s research arm – the National Institute for Health Research 2006/07 to £992 million a year by 2010. (NIHR) – and other public sector funders of medical research within a single integrated strategy through OSCHR will help to ensure Sir Leszek added: “The MRC has a huge role alongside NIHR of building the competitiveness of UK medical research in the future. The up the applicability of discovery into changes both in clinical practice comprehensive spending review (CSR) settlement will provide the seed and in drugs or other health interventions. We are working closely with corn from which we can produce improvements in human health more NIHR to develop joint implementation plans that will help us to achieve quickly and more efficiently in the coming years.” these goals, and will be announcing some initiatives soon.” AUTUMN 2007 CONTENTS Sir Leszek’s Journey 03 MRC says farewell to to the MRC Colin Blakemore Sir Leszek has a clinical academic background From vaccines to vision 04 RCUK Beijing office to help in viral immunology, infectious diseases, The past few decades have seen fantastic integrate research cell mediated immunity, virus associated developments in medical research. But 04 Joint ethics project with China malignancy and vaccine development. He Sir Leszek argues that the MRC’s duty to was born and schooled in Wales and studied make best use of these discoveries presents 05 Battling germs: new tactics medicine at the Welsh National School of both a challenge and an opportunity: “The Medicine. He came to London to further his unravelling of the human genome is a good 05 Biomarkers studies funded medical training at Hammersmith Hospital, example. We’ve got to actually get the benefits where he was attracted to the research of the human genome out. That means Research centre news 06 environment and became an MRC training concentration on basic mechanisms and how 06 NC3Rs: minimising the fellow to study viral immunology. Throughout the genes translate into products and into use of animals the first part of a distinguished career Sir novel mechanisms. And that should allow us Leszek held positions at hospitals in London, a greater and better understanding of disease 07 Opportunities Cambridge, The Gambia and Wales. processes and how they will actually impact.” He continued: “And at the clinical end, we 08 Weighing the economic He became head of the Faculty of Medicine have to better understand disease processes benefits of medical research at Imperial College London in 2001 and as they affect the individual and as they affect was promoted to Deputy Rector in 2004. In communities. Those are two very important 08 Tackling the toxic this role, Sir Leszek was responsible for the elements; from my own experience, I think the 09 Industry update overall academic and scientific direction of two are inextricably intertwined.” the college, particularly the development of 10 Unit profile: MRC inter-disciplinary research between engineering, Dr Richard Henderson, former Director of Laboratories, The Gambia physical sciences and biomedicine. the MRC Laboratory of Molecular Biology (LMB), also welcomed his appointment: “I was 13 MRC people Sir Leszek knows the MRC well. As well as delighted to learn that Sir Leszek Borysiewicz 14 Obituaries beginning his career with an MRC Clinical is the MRC’s new Chief Executive. As chair of Training Fellowship, he chaired the MRC the Molecular and Cellular Medicine Board we 15 Regulatory support centre Molecular and Cellular Medicine Board and found him to be very perceptive, knowledgeable up and running served on the MRC Council between 1995 and fair. He will be a great advocate for both and 2000. Between 1996 and 2001, Sir Leszek basic science and translation.” 15 Mental Capacity Act chaired a joint Department of Health/MRC advisory group that reviewed research and Another key theme in Sir Leszek’s vision is 16 Research roundup coordinated the human health research that the MRC continues to invest in training 18 Public engagement strategy on Creutzfeldt-Jakob Disease. the next generation of researchers who will bring forth their skills, knowledge and talent for 20 MRC Annual Review A founding fellow of the Academy of Medical the benefit of the wider community. “It is a big Sciences in 1996, Sir Leszek was a member of responsibility because these researchers will be 20 Molecular machines at the the Council of Cancer Research UK from 2002 behind discoveries of the future,” he said. MRC Virology Unit to 2005 and a governor of the Wellcome Trust from 2006 to 2007. In 2001 he was knighted Global health is also key to Sir Leszek’s strategy. for his services to developing vaccines, He said: “We have to be aware that we don’t including one to prevent cervical cancer. On live in global isolation in the UK and that issues appointment to the MRC, Sir Leszek retains no that surround global health are going to be of affiliation to any academic institution, except critical importance - the MRC has to play its for a single position as honorary consultant at part in ensuring that what we do is applicable St Mary’s Hospital in London. to the wider world community.” 2 NETWORK Autumn 2007 MRC says farewell to Colin Blakemore Professor Colin Blakemore finished his term as Chief Executive of the MRC at the end of September. Among his many achievements are his unfailing dedication to science communication and his commitment to using medical research to benefit people’s health. When he started his term at the MRC, Professor Colin Blakemore was asked if he would regret giving up the freedom of academic life and the excitement of research for pen-pushing in London. His reply was that the challenge of spending nearly half a billion pounds a year to nurture UK biomedical research was a huge honour – and, in any case, he had no intention of giving up research. “Colin has raised the public and professional profile of the MRC nationally and internationally and has effectively engaged the community in responding to changing research and Colin put the MRC at the forefront of new efforts to translate discovery financial environments,” said Sir John Chisholm, Chairman of the MRC.
Load more

Recommended publications
  • Mothers in Science
    The aim of this book is to illustrate, graphically, that it is perfectly possible to combine a successful and fulfilling career in research science with motherhood, and that there are no rules about how to do this. On each page you will find a timeline showing on one side, the career path of a research group leader in academic science, and on the other side, important events in her family life. Each contributor has also provided a brief text about their research and about how they have combined their career and family commitments. This project was funded by a Rosalind Franklin Award from the Royal Society 1 Foreword It is well known that women are under-represented in careers in These rules are part of a much wider mythology among scientists of science. In academia, considerable attention has been focused on the both genders at the PhD and post-doctoral stages in their careers. paucity of women at lecturer level, and the even more lamentable The myths bubble up from the combination of two aspects of the state of affairs at more senior levels. The academic career path has academic science environment. First, a quick look at the numbers a long apprenticeship. Typically there is an undergraduate degree, immediately shows that there are far fewer lectureship positions followed by a PhD, then some post-doctoral research contracts and than qualified candidates to fill them. Second, the mentors of early research fellowships, and then finally a more stable lectureship or career researchers are academic scientists who have successfully permanent research leader position, with promotion on up the made the transition to lectureships and beyond.
    [Show full text]
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Discovery and Assessment of Conserved Pax6 Target Genes and Enhancers
    Edinburgh Research Explorer Discovery and assessment of conserved Pax6 target genes and enhancers Citation for published version: Coutinho, P, Pavlou, S, Bhatia, S, Chalmers, KJ, Kleinjan, DA & van Heyningen, V 2011, 'Discovery and assessment of conserved Pax6 target genes and enhancers', Genome Research, vol. 21, no. 8, pp. 1349- 59. https://doi.org/10.1101/gr.124115.111 Digital Object Identifier (DOI): 10.1101/gr.124115.111 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Genome Research Publisher Rights Statement: Copyright © 2011 by Cold Spring Harbor Laboratory Press. EuropePMC open access link General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 26. Sep. 2021 Method Discovery and assessment of conserved Pax6 target genes and enhancers Pedro Coutinho,1 Sofia Pavlou, Shipra Bhatia, Kevin J. Chalmers, Dirk A. Kleinjan, and Veronica van Heyningen Medical Research Council (MRC) Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom The characterization of transcriptional networks (TNs) is essential for understanding complex biological phenomena such as development, disease, and evolution.
    [Show full text]
  • Driving Diffusion of Scientific Innovation
    Driving Diffusion of Scientific Innovation - The Role of Institutional Entrepreneurship and Open Science in Synthetic Biology Vom Promotionsausschuss der Technischen Universit¨at Hamburg-Harburg zur Erlangung des akademischen Grades Doktor der Wirtschafts- und Sozialwissenschaften (Dr. rer. pol.) genehmigte Dissertation von Giulio Barth aus M¨unster 2018 Advisors: Prof. Dr. C. Ihl, Prof. Dr. M. G. M¨ohrle Institute of Entrepreneurship, TUHH i Gutachter: Prof. Dr. C. Ihl Prof. Dr. M. G. Mohrle¨ Vorsitz: Prof. Dr. C. Luthje¨ Tag der mundlichen¨ Prufung:¨ 14. September 2018 ”Our victory: inevitable; our timing: uncertain.” (Drew Endy, Assistant Professor Stanford University) i Abstract Scientific innovations need to widely diffuse to fully exploit their potential. Prior research investigated levers on the diffusion of scientific innovation with particular interest on institutions, e.g., settings of property rights. As institutional theory lacks in explaining emergence and shaping of institu- tions, the institutional entrepreneur approach faces these limitations. Key actors combine logics from multiple fields and convince their social context of their ideas to legitimate the creation of new institutions and shape an emerging field. This thesis validates theories on institutional entrepreneurs and investigates the end-to process from diffusing a logic to the impact of an established insti- tution on scientific innovations in context of the emerging synthetic biology. The field is expected to introduce the 5th revolution and characterized by the central logic of making biology an engineering discipline. In chapter 4 theories on institutional entrepreneurs driving diffusion of in- stitutional logics to shape an emerging field are validated. To measure the social influence mechanisms, the heterogeneous diffusion model is adapted to the institutional logic.
    [Show full text]
  • Regulationseinheiten in Evolution, Entwicklung Und Humaner Krankheit
    Regulatory units in evolution, development, and human disease Regulationseinheiten in Evolution, Entwicklung und humaner Krankheit Der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr.rer.nat. vorgelegt von Lifei Li Als Dissertation genehmigt von der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Tag der mündlichen Prüfung: 28.05.2020 Vorsitzender des Promotionsorgans: Prof. Dr. Georg Kreimer Gutachter: Prof. Dr. Leila Taher Prof. Dr. Christian Pilarsky Declaration of Authorship I, Lifei Li, declare that this thesis, titled “Regulatory units in evolution, development, and human disease”, and the work presented in it are my own. I confirm that I did not submit previously any part of this thesis for any degree or any other qualification at Friedrich-Alexander University Erlangen-Nürnberg, nor at any other institution. I also declare that, where I have consulted the published work of others, this is always clearly attributed, and where I have quoted from the work of others, the source is always given. I also confirm that, where the thesis is based on work done by myself jointly with others, I have made clear exactly what was done by others and what I have contributed myself. i Abstract Misregulation of gene expression can result in broad types of diseases and abnormalities. For elucidating the molecular mechanisms underlying evolution, development and disease, the 2% protein-coding regions in the human genome have been studied for decades, but the the 98% non-coding regions remain less understood. Many studies have revealed that evolutionary con- served non-coding elements (CNEs) act as cis-regulatory elements (CREs).
    [Show full text]
  • Annual Report 2010 © Copyright 2011
    Centre for Genomic Regulation Annual Report 2010 © Copyright 2011 Produced by: Department of Communication & Public Relations Centre for Genomic Regulation (CRG) Dr. Aiguader, 88 08003 Barcelona, Spain www.crg.eu Texts and graphics: CRG Researchers, Department of Communication and Public Relations Graphic Design: Genoma ArtStudio SCP (www.genoma-artstudio.com) Photography: Ivan Martí Printing: Novoprint, S.A. Legal deposit: B-24966-2011 CONTENTS CRG Scientific Structure 6 CRG Core Facilities Structure 8 CRG Management Structure 10 CRG Scientific Advisory Board (SAB) 12 CRG Business Board 13 Year Retrospect by the Director of the CRG: Miguel Beato 14 Research Programmes Gene Regulation 16 > Chromatin and gene expression 18 > Regulation of alternative pre-mRNA splicing during cell differentiation, development and disease 22 > Regulation of protein synthesis in eukaryotes 26 > Translational control of gene expression 29 Differentiation and Cancer 34 > Hematopoietic differentiation and stem cell biology 36 > Reprogramming and regeneration 40 > Epigenetics events in cancer 43 > Epithelial homeostasis and cancer 48 > Mechanisms of cancer and aging 51 Genes and Disease 54 > Genetic causes of disease 56 > Gene therapy 65 > Gene Function and murine models of disease 69 > Neurobehavioral phenotyping of mouse models of disease 73 > Genomic and epigenomic variation in disease 77 Bioinformatics and Genomics 82 > Bioinformatics and genomics 84 > Comparative bioinformatics 92 > Comparative genomics 96 > Evolutionary genomics 101 > Gene function and evolution
    [Show full text]
  • Mechanisms Directing Receptor-Specific Gene Regulation
    Mechanisms Directing Receptor-Specific Gene Regulation by the Androgen and Glucocorticoid Receptor Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry, Pharmacy of Freie Universität Berlin by Marina Kulik • 2021 The dissertation was prepared under the supervision of Dr. Sebastiaan H. Meijsing at the Max Planck Institute for Molecular Genetics in Berlin from September 2015 to February 2021. 1st Reviewer: Dr. Sebastiaan Meijsing 2nd Reviewer: Prof. Dr. Markus Wahl Date of defense: 21.05.2021 1 Selbstständigkeitserklärung Hiermit bestätige ich, dass ich die vorliegende Arbeit selbstständig und unter Zuhilfenahme der angegebenen Literatur erstellt habe. Acknowledgments First of all, I would like to express my gratitude to my supervisor Sebastiaan Meijsing for his support and guidance during my PhD. I would like to thank Martin Vingron for the opportunity to be part of his research group and for the great collaborations. Especially, I would like to thank Stefan Haas for introducing me to the world of RNA-seq and Gözde Kibar, who contributed with her bioinformatical analyses to this work. I would like to thank Sarah Kinkley for her support and for giving me the opportunity to finish my PhD in her group. I wish to thank Stefan Prekovic, Isabel Mayayo-Peralta and Wilbert Zwart from the NKI in Amsterdam for sharing their expertise in “nuclear signaling” and the great collaboration. I am particularly grateful to Melissa Bothe, her computational analyses and support in the lab contributed a lot to this work. My special gratitude goes to Laura Glaser for her continuous advice and for freezing my cells in the evening countless times.
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • A Novel Optical Microscope for Imaging Large
    RESEARCH ARTICLE A novel optical microscope for imaging large embryos and tissue volumes with sub-cellular resolution throughout Gail McConnell1*, Johanna Tra¨ ga˚ rdh1, Rumelo Amor1, John Dempster1, Es Reid1, William Bradshaw Amos1,2 1Centre for Biophotonics, Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom; 2MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Abstract Current optical microscope objectives of low magnification have low numerical aperture and therefore have too little depth resolution and discrimination to perform well in confocal and nonlinear microscopy. This is a serious limitation in important areas, including the phenotypic screening of human genes in transgenic mice by study of embryos undergoing advanced organogenesis. We have built an optical lens system for 3D imaging of objects up to 6 mm wide and 3 mm thick with depth resolution of only a few microns instead of the tens of microns currently attained, allowing sub-cellular detail to be resolved throughout the volume. We present this lens, called the Mesolens, with performance data and images from biological specimens including confocal images of whole fixed and intact fluorescently-stained 12.5-day old mouse embryos. DOI: 10.7554/eLife.18659.001 Introduction During experiments with laser scanning confocal microscopes in the mid-1980s, it became obvious that the optical sectioning, which is the main advantage of the confocal method, did not work with *For correspondence: the available low-magnification objectives, because of their low numerical aperture (N.A.) [email protected] (White et al., 1987). In specimens such as mouse embryos at the 10–12.5 day stage, when the major Competing interest: See organs are developing (Kaufman, 1992), it was impossible to see individual cells in the interior page 14 despite the lateral (XY) resolution being sufficient.
    [Show full text]
  • Print ED376034.TIF
    DOCUMENT RESUME ED 376 034 SE 054 720 TITLE Grants for Science Education, 1994. INSTITUTION Howard Hughes Medical Inst., Chevy Chase, MD. Office of Grants and Special Programs. PUB DATE 94 NOTE 151p. AVAILABLE FROM Howard Hughes Medical Institute, Office of Grants and Special Programs, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789. PUB TYPE Guides Non-Classroom Use (055) EDRS PRICE MF01/PC07 Plus Postage. DESCRIPTORS *Biomedicine; *Grants; Higher Education; *Research; *Science Education; Secondary Education ABSTRACT To help strengthen education in medicine, biology, and related sciences, the Howard,Hughes Medical Institute (HHMI) launched a grants program in those areas on 1987. The grants support graduate, undergraduate, precollege and public science education, and fundamental biomedical research abroad. This document provides summaries of all projects receiving grants in 1993 and is also, in effect, a 1993 annual report for each programmatic area supported by HHMI. (ZWH) *********************************************************************** Reproductions supplied by EDRS are the best that can be made * from the original document. * *********************************************************************** a$ 8 , 1 i 111 I z t S I I A U R DEPARTMENT OF EDUCATION TO REPRODUCETHIS Once of EdocAi oda, Osearco Inc Imow.emedi ' PERMISSION GRANTED BY EOUCATIONAL RESONTER URCESINFORMATION MATERIAL HAS BEEN CE IERIC) ^, s document .as Deed reorocucec as eeReed oom toe owsed dr otogm.at, 6 - onginalmgI C Mdot changes nays oeed made to tooro,, .eooduc hod 0,4401' Points oI A* or opmods staled.. to.sdoco°P.m RESOURCES e'en, 00 °Ot nedossAnIY Ieptesedt TO THE EDUCATIONAL OERI DoSMod ot ("WY INFORMATION CENTER(ERIC) BEST COPY AVAILA Copyright ©1994 by the Howard Hughes Medical Institute Office of Grants and Special Programs.
    [Show full text]
  • A Novel Optical Microscope for Imaging Large Embryos And
    RESEARCH ARTICLE A novel optical microscope for imaging large embryos and tissue volumes with sub-cellular resolution throughout Gail McConnell1*, Johanna Tra¨ ga˚ rdh1, Rumelo Amor1, John Dempster1, Es Reid1, William Bradshaw Amos1,2 1Centre for Biophotonics, Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom; 2MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Abstract Current optical microscope objectives of low magnification have low numerical aperture and therefore have too little depth resolution and discrimination to perform well in confocal and nonlinear microscopy. This is a serious limitation in important areas, including the phenotypic screening of human genes in transgenic mice by study of embryos undergoing advanced organogenesis. We have built an optical lens system for 3D imaging of objects up to 6 mm wide and 3 mm thick with depth resolution of only a few microns instead of the tens of microns currently attained, allowing sub-cellular detail to be resolved throughout the volume. We present this lens, called the Mesolens, with performance data and images from biological specimens including confocal images of whole fixed and intact fluorescently-stained 12.5-day old mouse embryos. DOI: 10.7554/eLife.18659.001 Introduction During experiments with laser scanning confocal microscopes in the mid-1980s, it became obvious *For correspondence: that the optical sectioning, which is the main advantage of the confocal method, did not work with [email protected] the available low-magnification objectives, because of their low numerical aperture (N.A.) Competing interest: See (White et al., 1987). In specimens such as mouse embryos at the 10–12.5 day stage, when the major page 14 organs are developing (Kaufman, 1992), it was impossible to see individual cells in the interior despite the lateral (XY) resolution being sufficient.
    [Show full text]
  • Smutty Alchemy
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2021-01-18 Smutty Alchemy Smith, Mallory E. Land Smith, M. E. L. (2021). Smutty Alchemy (Unpublished doctoral thesis). University of Calgary, Calgary, AB. http://hdl.handle.net/1880/113019 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Smutty Alchemy by Mallory E. Land Smith A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN ENGLISH CALGARY, ALBERTA JANUARY, 2021 © Mallory E. Land Smith 2021 MELS ii Abstract Sina Queyras, in the essay “Lyric Conceptualism: A Manifesto in Progress,” describes the Lyric Conceptualist as a poet capable of recognizing the effects of disparate movements and employing a variety of lyric, conceptual, and language poetry techniques to continue to innovate in poetry without dismissing the work of other schools of poetic thought. Queyras sees the lyric conceptualist as an artistic curator who collects, modifies, selects, synthesizes, and adapts, to create verse that is both conceptual and accessible, using relevant materials and techniques from the past and present. This dissertation responds to Queyras’s idea with a collection of original poems in the lyric conceptualist mode, supported by a critical exegesis of that work.
    [Show full text]